Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-24

Clinical Trial Update: Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a combination of remimazolam and propofol for sedation during drug-induced sleep endoscopy in obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROPOFOL (Propofol)
  • Remimazolam (remimazolam)

Snippet

Sponsor: Dan Liu | Conditions: Sedative Effect During Drug-induced Sleep Endoscopy, Obstructive Sleep Apnea (OSA) | Phase 4 | Status: ACTIVE_NOT_RECRUITING